BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5695)

  • 1. [Methods of determination of the turnover rate of neuromediators (author's transl)].
    Poitou P; Bohuon C
    Pathol Biol (Paris); 1976 Feb; 24(2):149-52. PubMed ID: 5695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitors of catecholamine biosynthesis (review of the literature)].
    Frantsuzova SB
    Farmakol Toksikol; 1973; 36(5):624-8. PubMed ID: 4150865
    [No Abstract]   [Full Text] [Related]  

  • 3. A critical assessment of methods for the determination of monoamine synthesis turnover rates in vivo.
    Weiner N
    Adv Biochem Psychopharmacol; 1974; 12(0):143-59. PubMed ID: 4153830
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of enzymes that synthesize neurotransmitter monoamines.
    Fuller RW; Steinberg M
    Adv Enzyme Regul; 1976; 14():347-390. PubMed ID: 9790
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 6. The activity of tyrosine hydroxylase in intact adrenergic neurons of the mouse vas deferens.
    Bjur RA; Weiner N
    J Pharmacol Exp Ther; 1975 Jul; 194(1):9-26. PubMed ID: 239222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The monoamines in molluscs. I. Catecholamines: biosynthesis, disposition and inactivation (author's transl)].
    Cardot J
    J Physiol (Paris); 1979; 75(7):689-713. PubMed ID: 44729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and animal experiments concerning the function of brain catecholamines.
    Matussek N
    Int Pharmacopsychiatry; 1971; 6(3):170-86. PubMed ID: 4950569
    [No Abstract]   [Full Text] [Related]  

  • 9. [Enzymatic methods for the identification of a transmitter substance in a specific brain nucleus (author's transl)].
    Kataoka K; Sorimachi M
    Tanpakushitsu Kakusan Koso; 1974 Jul; 19(7):537-49. PubMed ID: 4154482
    [No Abstract]   [Full Text] [Related]  

  • 10. Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain.
    Waldeck B
    J Pharm Pharmacol; 1971 Nov; 23(11):824-30. PubMed ID: 4400189
    [No Abstract]   [Full Text] [Related]  

  • 11. Reserpine-like effects of harmine on isolated adrenal medullary vesicles.
    Green HO; Slotkin TA
    Mol Pharmacol; 1973 Nov; 9(6):748-55. PubMed ID: 4148654
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular geometry and adrenergic drug activity.
    Patil PN; Miller DD; Trendelenburg U
    Pharmacol Rev; 1974 Dec; 26(4):323-92. PubMed ID: 4156804
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of catecholamine turnover by variations of enzyme levels.
    Pletscher A
    Pharmacol Rev; 1972 Jun; 24(2):225-32. PubMed ID: 4404611
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition by hydralazine of catecholamine biosynthesis in cultured bovine adrenal medullary cells.
    Houchi H; Morita K; Minakuchi K; Oka M
    Biochem Pharmacol; 1986 Jun; 35(12):2047-9. PubMed ID: 2872897
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of monoamine biosynthesis by calmodulin-dependent protein kinase in the nervous system.
    Fujisawa H; Yamauchi T; Okuno S; Nakata H
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():503-10. PubMed ID: 6145330
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphological contributions to monoamine pharmacology.
    Hökfelt T
    Fed Proc; 1974 Oct; 33(10):2177-86. PubMed ID: 4138494
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical pharmacology of the central nervous system. 6. Specific inhibitors of enzymes implied in the synthesis of cerebral serotonin].
    Corgier M; Pacheco H
    Therapie; 1973; 28(4):639-49. PubMed ID: 4793684
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the mechanism of therapeutic actions of psychotropic drugs (author's transl)].
    Mroji T
    No To Shinkei; 1979 Nov; 31(11):1075-97. PubMed ID: 43160
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.